Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal skeletal muscle morphology (HP:0011805)help
Parent Node:
expand
Abnormal muscle fiber morphology (HP:0004303)help
..Starting node
..expand
Abnormal muscle glycogen content (HP:0012269)help
Term ID: 12269
Name: Abnormal muscle glycogen content
Synonym:
Definition: Any anomaly in the amount of glycogen in muscle tissue.
Comments:
Reference: HP:0012269
Genes and Diseases:
 
       Child Nodes:
........expandIncreased muscle glycogen content (HP:0009051) help
................... HP:0030231 Glycogen accumulation in muscle fiber lysosomes
................... HP:0030232 Increased sarcoplasmic glycogen
........expandDecreased muscle glycogen content (HP:0012270) help

 Sister Nodes: 
..expandAbnormal muscle fiber protein expression (HP:0030089) help
..expandAbnormality of skeletal muscle fiber size (HP:0012084) help
..expandAutophagic vacuoles (HP:0003736) help
..expandCentral core regions in muscle fibers (HP:0030230) help
..expandCentrally nucleated skeletal muscle fibers (HP:0003687) help
..expandDeposits immunoreactive to beta-amyloid protein (HP:0003791) help
..expandHypertrophied muscle fibers (HP:0100293) help
..expandIncreased endomysial connective tissue (HP:0100297) help
..expandIncreased muscle lipid content (HP:0009058) help
..expandInternally nucleated skeletal muscle fibers (HP:0031237) help
..expandMotheaten muscle fibers (HP:0100298) help
..expandMuscle fiber atrophy (HP:0100295) help
..expandMuscle fiber inclusion bodies (HP:0100299) help
..expandMuscle fiber necrosis (HP:0003713) help
..expandMuscle fiber splitting (HP:0003555) help
..expandMyelin-like whorls in vacuolated fibers (HP:0031542) help
..expandNecklace skeletal muscle fibers (HP:0031238) help
..expandPerifascicular muscle fiber atrophy (HP:0100296) help
..expandRagged-red muscle fibers (HP:0003200) help
..expandReduced muscle carnitine level (HP:0030362) help
..expandRimmed vacuoles (HP:0003805) help
..expandRing fibers (HP:0100305) help
..expandType 1 muscle fiber predominance (HP:0003803) help
..expandType 2 muscle fiber predominance (HP:0010602) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0012269HP:0012269Abnormal muscle glycogen content0ENO3 CL E G H20273354OMIM:612932Glycogen storage disease XIII34
HP:0012269HP:0012269Abnormal muscle glycogen content0GAA CL E G H25484065OMIM:232300Glycogen storage disease II407
HP:0012269HP:0012269Abnormal muscle glycogen content0GYG1 CL E G H29924699ORPHA:263297Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency18
HP:0012269HP:0012269Abnormal muscle glycogen content0GYS1 CL E G H29974706OMIM:611556Glycogen storage disease 0, muscle52
HP:0012269HP:0012269Abnormal muscle glycogen content0MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome
HP:0012269HP:0012269Abnormal muscle glycogen content0PFKM CL E G H52138877ORPHA:371Glycogen storage disease due to muscle phosphofructokinase deficiency64
HP:0012269HP:0012269Abnormal muscle glycogen content0PFKM CL E G H52138877OMIM:232800Glycogen storage disease VII64
HP:0012269HP:0012269Abnormal muscle glycogen content0PHKA1 CL E G H52558925OMIM:300559Muscle glycogenosis, X-linked54
HP:0012269HP:0012269Abnormal muscle glycogen content0PHKA2 CL E G H52568926ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiency54
HP:0012269HP:0012269Abnormal muscle glycogen content0PHKB CL E G H52578927OMIM:261750Glycogen storage disease ixb101
HP:0012269HP:0012269Abnormal muscle glycogen content0PHKG2 CL E G H52618931ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiency48
HP:0012269HP:0012269Abnormal muscle glycogen content0PYGM CL E G H58379726ORPHA:368Glycogen storage disease due to muscle glycogen phosphorylase deficiency166
HP:0012269HP:0012269Abnormal muscle glycogen content0TRMU CL E G H5568725481ORPHA:254864Mitochondrial myopathy with reversible cytochrome C oxidase deficiency101
HP:0012269HP:0012269Abnormal muscle glycogen content0TRNE CL E G H45567479ORPHA:254864Mitochondrial myopathy with reversible cytochrome C oxidase deficiency
HP:0012269HP:0009051Increased muscle glycogen content1ENO3 CL E G H20273354OMIM:612932Glycogen storage disease XIII.34
HP:0012269HP:0009051Increased muscle glycogen content1GAA CL E G H25484065OMIM:232300Glycogen storage disease II407
HP:0012269HP:0012270Decreased muscle glycogen content1GYG1 CL E G H29924699ORPHA:263297Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiencyHP:0040282 - Frequent18
HP:0012269HP:0012270Decreased muscle glycogen content1GYS1 CL E G H29974706OMIM:611556Glycogen storage disease 0, muscle52
HP:0012269HP:0009051Increased muscle glycogen content1MSTO1 CL E G H5515429678ORPHA:502423Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndromeHP:0040282 - Frequent
HP:0012269HP:0009051Increased muscle glycogen content1PFKM CL E G H52138877ORPHA:371Glycogen storage disease due to muscle phosphofructokinase deficiencyHP:0040281 - Very frequent64
HP:0012269HP:0009051Increased muscle glycogen content1PFKM CL E G H52138877OMIM:232800Glycogen storage disease VII.64
HP:0012269HP:0009051Increased muscle glycogen content1PHKA1 CL E G H52558925OMIM:300559Muscle glycogenosis, X-linked54
HP:0012269HP:0009051Increased muscle glycogen content1PHKA2 CL E G H52568926ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiency54
HP:0012269HP:0009051Increased muscle glycogen content1PHKB CL E G H52578927OMIM:261750Glycogen storage disease ixb.101
HP:0012269HP:0009051Increased muscle glycogen content1PHKG2 CL E G H52618931ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiency48
HP:0012269HP:0009051Increased muscle glycogen content1PYGM CL E G H58379726ORPHA:368Glycogen storage disease due to muscle glycogen phosphorylase deficiencyHP:0040281 - Very frequent166
HP:0012269HP:0009051Increased muscle glycogen content1TRMU CL E G H5568725481ORPHA:254864Mitochondrial myopathy with reversible cytochrome C oxidase deficiencyHP:0040281 - Very frequent101
HP:0012269HP:0009051Increased muscle glycogen content1TRNE CL E G H45567479ORPHA:254864Mitochondrial myopathy with reversible cytochrome C oxidase deficiencyHP:0040281 - Very frequent
HP:0012269HP:0030231Glycogen accumulation in muscle fiber lysosomes2PHKA1 CL E G H52558925OMIM:300559Muscle glycogenosis, X-linked54
HP:0012269HP:0030232Increased sarcoplasmic glycogen2PHKA2 CL E G H52568926ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiencyHP:0040283 - Occasional54
HP:0012269HP:0030232Increased sarcoplasmic glycogen2PHKG2 CL E G H52618931ORPHA:264580Glycogen storage disease due to liver phosphorylase kinase deficiencyHP:0040283 - Occasional48
HP:0012269HP:0030231Glycogen accumulation in muscle fiber lysosomes2PYGM CL E G H58379726ORPHA:368Glycogen storage disease due to muscle glycogen phosphorylase deficiencyHP:0040281 - Very frequent166


Genes (13) :ENO3 GAA GYG1 GYS1 MSTO1 PFKM PHKA1 PHKA2 PHKB PHKG2 PYGM TRMU TRNE

Diseases (12) :OMIM:612932 OMIM:232300 ORPHA:263297 OMIM:611556 ORPHA:502423 ORPHA:371 OMIM:232800 OMIM:300559 ORPHA:264580 OMIM:261750 ORPHA:368 ORPHA:254864
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.